Awardee OrganizationSCRIPPS RESEARCH INSTITUTE, THE
Description
Abstract Text
Abstract
Protracted withdrawal is characterized by negative emotional symptoms and their alleviation is a driving force
for continued alcohol consumption. Our TSRI-ARC focuses on identifying the enduring neuroadaptations in the
brain stress systems that drive relapse. In rats with ethanol dependence, an overactivation of the central nucleus
of the amygdala (CeA) is driven by recruitment of the corticotropin-releasing factor (CRF) and CRF1 receptors
(CRF1). Nociceptin/orphanin FQ (N/OFQ) peptide and its receptor (NOP) exert anti-stress effects by
counteracting the function of endogenous CRF in CeA. The infralimbic (IL) subdivision of the mPFC exerts “top-
down” control over the amygdala to regulate emotional aspects of goal-directed behaviors. Our main hypothesis
is that dysfunction of mPFC contributes to the negative affect that drives withdrawal-induced drinking. We predict
that IL pyramidal neurons that project to CeA (ILàCeA) may normally inhibit ethanol seeking and drinking under
stress, a function that is compromised (decreased) in AUD, rendering subjects vulnerable to stress-induced
negative urgency for ethanol. Preliminary chemogenetic data from Zorrilla’s component point to a causal role of
rat ILàCeA inhibition in negative affect. Moreover, Martin-Fardon’s component showed that intra-IL CRF1 or
hypocretin/orexin (Hcrt) antagonist infusion reduced stress-induced reinstatement of ethanol seeking in rats.
These peptides are highly expressed in IL, but their interplay is understudied. The Neurophysiology Project
(Lead: Roberto; Co-Lead: Bajo) will elucidate the mechanisms and neurotransmitters that disrupt IL functions
and identify the ILàCeA role in these behavioral phenotypes. We will test the hypothesis that ethanol
dependence [induced by chronic intermittent ethanol (CIE)] and abstinence produce an imbalance between brain
stress (e.g., CRF) and anti-stress (e.g., N/OFQ) systems within the ILàCeA circuitry. Here we show that 1) CRF
decreases spontaneous GABA release but increases glutamate release onto layer V IL pyramidal neurons of
naïve male rats, 2) the CRF-associated reduction of GABA release onto ILàCeA neurons is stronger than onto
other IL neurons. Our preliminary data support that the ILàCeA neurons represent a subset of neurons with
unique electrophysiological properties and responsiveness to dependence/withdrawal that account for a
decrease in ILàCeA connectivity. Moreover, CRF-induced facilitation of glutamate release and firing are
opposed by N/OFQ in the IL. Thus, this proposal will a) investigate the mechanisms mediating N/OFQ and CRF
modulation of overall IL function (Specific Aim 1) and b) will unveil the unique electrophysiological properties of
IL pyramidal neurons that project to CeA and their role in negative behavioral symptomatology of ethanol
withdrawal (Specific Aim 2). This project will use ex vivo electrophysiology and proteomics of circuit-defined
neurons, protein assays, in situ hybridization, neuronal tracing, chemogenetics, and behavioral testing. These
techniques will involve the Animal Models and Neuroproteomics Cores, and collaborations with the Zorrilla,
Martin-Fardon, Contet, and George Components.
PHS 398/2590 (Rev. 06/09) Page Continuation Format Page
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
DUNS Number
781613492
UEI
PHZJFZ32NKH4
Project Start Date
01-December-1983
Project End Date
31-December-2027
Budget Start Date
01-January-2024
Budget End Date
31-December-2024
Project Funding Information for 2024
Total Funding
$219,627
Direct Costs
$129,804
Indirect Costs
$89,823
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$219,627
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P60AA006420-41 5136
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P60AA006420-41 5136
Patents
No Patents information available for 5P60AA006420-41 5136
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P60AA006420-41 5136
Clinical Studies
No Clinical Studies information available for 5P60AA006420-41 5136
News and More
Related News Releases
No news release information available for 5P60AA006420-41 5136
History
No Historical information available for 5P60AA006420-41 5136
Similar Projects
No Similar Projects information available for 5P60AA006420-41 5136